BTIG Maintains Buy on Astrana Health, Raises Price Target to $50

Benzinga Newsdesk www.benzinga.com Positive 71.3%

Neg 0% Neu 0% Pos 71.3%

BTIG analyst David Larsen maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $40 to $50.